DRKS00028806招募中不适用
Registry of the molekularen tumor boards of the University Cancer Centers Schleswig-Holstein (short title: „UCCSH-MTB-registry)
niversitätsklinikum Schleswig-Holstein, Lübeck Klinik für Hämatologie und Onkologie0 个研究点目标入组 1,000 人开始时间: 2022年5月9日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 199 Years（—）
- 性别
- All
入选标准
- •Referral to the molecular tumor board
排除标准
- •informed consent not signed
研究者
相似试验
招募中
不适用
Molecular Tumor Board - A Registry of the East German Hematology and Oncology Study Group.hematologic or oncologic diseasesDRKS00032977Martin-Luther-Universität Halle-Wittenberg250
招募中
不适用
Register study of the Molecular Tumor Board (tumor entity-spanning molecular characterization program to evaluate individualized tumor biology-guided therapy in adults with rare and advanced tumor entities)Cross-tumor entity (adult patients = 18 years of age with any advanced tumor disease or with rare tumor entity (incidence of less than one case per 100,000 population)).N/ADRKS00025847niversitätsklinikum Freiburg Klinik für Innere Medizin I Schwerpunkt Hämatologie, Onkologie und Stammzelltransplantation1,000
招募中
不适用
The Cancer Molecular Screening and Therapeutics (MoST) Program-ScreeningCancer - Any cancerCancerACTRN12616000908437niversity of Sydney7,628
尚未招募
不适用
CIRculating Cell-free nUcLeic Acids in Cancer Therapy Monitoring -01Next-Generation-SequencingNCT05871593University Hospital Tuebingen200
尚未招募
不适用
Can interdisciplinary tumor boards for determining the further procedure in patients with urological carcinoma be equivalently replaced by appropriately trained Large Language Models (LLMs)? Results of a multicenter study on the concordance and differences in the recommendations of real tumor boards and virtual LLM tumor boards.DRKS00034797Klinikum St. Elisabeth Straubing100